ISSN 2415-3060 (print), ISSN 2522-4972 (online)
  • 12 of 41
JMBS 2017, 2(5): 59–63
Experimental Medicine and Morphology

Diffuse Endocrine System (DES) Cells of the Uterus Endometrium of Intact Rats in Different Phases of the Estrous Cycle

Pelin E., Globa T., Darius A., Globa L.

One of the important directions of contemporary gynaecological oncology is the study of various aspects of precancerous lesions pathogenesis and uterine cancer. The cells of diffuse endocrine system participate in the physiological and cyclical processes that take place in the genital organs, such as, the menstrual cycle in women and the oestrus in animals. Among all biogenic amines the serotonin is the most common in the diffuse endocrine system, which acts as a tissue hormone. The purpose of the study is examination of topography, morphology, and histophysiology of the uterine endocrine diffuse system cells in different estral cycle phases (estrus and estral rest) of intact rats. Materials and methods. The experiments were performed on laboratory white female rats with a body weight of 160-180 g, maintained into the standard vivarium conditions. The experimental material was divided into 2 groups (estrus and rest). Monitoring of estral cycle in rats was performed by vaginal cytology studying. Results and discussion. Serotonin-secreting cells with specific fluorescence were detected throughout the endometrium. Their density was 1792,8±76,11 much lower than in the control group (2010,47±101,59). The cells were characterized by small sizes and mostly by irregular or triangle shapes. Their volume was 922,97±52,93, which is much lower than in the control group (2964,32±67,64). In addition, the serotonin-secreting cells were contained fewer and smaller granules. Comparative to control group (17,77±0,14) one cell from this region had 10,82±0,17 granules in average. The fluorescence intensity was 0,12±0,002 units, which was lower than that recorded in the rest period (0,18±0,002). In addition to serotonin cells in the endometrium, fluorescent extracellular granules were also detected. They were in close proximity to the serotonin-secreting cells. Their density was 30076,7±1189,01 granules/1mm², which is practically similar to that of the control group (29491,38±930,14). The fluorescence intensity of those granules was 0,04±0,002 units, which was only slightly lower than in the control group (0,05±0,002). In estrus was observed the most low serotonin index (especially the intracellular serotonin) and secretory index (extracellular serotonin) comparative with the estral rest phase. Serotonin involvement in the cell differentiation and proliferation processes, both in physiological and embryonic cleavage conditions, opens the possibility of using this amine in medical practice. Thus, serotonin can be used in onco-gynecology to increase the resistance of the female body to cytostatic agents and to potentiate their therapeutic effect. However, until now, many important aspects of the histopathology and biochemistry of uterine DES cells remain unclarified, such as: changes in the synthesis and secretion of biologically active substances in physiological (estrus, ovarian-menstrual cycle, gestation, labour, post-partum involution) and pathological conditions (inflammation, tumour growth); the possibility of controlled change of these functions in order to correct deviations from the norm and for therapeutic purposes. Conclusion. Oestrus is characterized by quantitative diminution of DES cells in the endometrium, numeric reduction of serotoninic granules in the cells, decreased fluorescence, but with constant extracellular granules number maintaining. These data shows that the uterine decreasing of serotonin in oestrus is produced predominantly by slowed down synthesis and accumulation processes, but not by cell secretion increasing.

Keywords: diffuse endocrine system, uterus, serotonin, oestrus

Full text: PDF (Rus) 206K

  1. Benetato G, Uluitu M, Bonciocat C, Suhaciu GH, Neculau V. The effect of reserpine and of sectioning of the medial forebrain bundle on the estral cycle in rats in terms of the serotonin content in the rhinencephalon and hypotalamus. Roumaine physiol. 1967; 4: 89-105.
  2. Dynarowicz I, Watkowski T, Dziegielewski M. Analysis of the effects of oxytocin, vasopressin, angiotensin, serotonin and histamine on the blood flow in the reproductive organs of swine the during estrous cycle. Pol Arch Weter. 1988; 28 (1-2): 99-111.
  3. Ichida S, Oda Y, Tokunaga H, Hayashi T, Murakami T, Kita T. Mechanisms of specific change by estradiol in sensitivity of rat uterus to serotonin. J Pharmacol Exp Ther. 1984 Apr; 229 (1): 244-9.
  4. Johnson JH, Kitts CS. Serotoninergic mediation of a negative feedback effect of estrogen on luteinizing hormone release in ovariectomized rats. Endocrinology. 1988 Nov; 123 (5): 2270-5.
  5. Juorio AV, Chedrese PJ, Li XM. The influence of ovarian hormones on the rat oviductal and uterine concentration of noradrenaline and 5-hydroxytryptamine. Neurochem Res. 1989 Sep; 14 (9): 821-7.
  6. Klink R, Robichaud M, Debonnel G. Gender and gonadal status modulation of dorsal raphe nucleus serotonergic neurons. Part I: effects of gender and pregnancy. Neuropharmacology. 2002 Dec; 43 (7): 1119-28.
  7. Laudon M, Yaron Z, Zisapel N. N-(2,4-dinitrophenyl)-5-methoxytryptamine, a novel melatonin antagonist: effects on sexual maturation of the male and female rat and on oestrous cycles of the female rat (corrected). J Endocrinol. 1988 Jul; 118 (1): 168.
  8. Certificat de inovator № 4426 (Moldova). Metoda de determinare a indicelui de secreţie a serotoninocitelor sistemului endocrin difuz (SED) / Lutan Vasile, Pelin Elina; din 23.02.2006a.
  9. Certificat de inovator № 4427 (Moldova). Metoda de determinarea indicelui serotoninic al sistemului endocrin difuz / Lutan Vasile, Pelin Elina; din 23.02.2006b.
  10. Mencaglia L. Endometrial cytology: six years of experience. Diagn Cytopathol. 1987 Sep; 3 (3): 185-90.
  11. Pelin E. Acţiunea hormonilor estrogeni şi progestinelor asupra sistemului endocrin difuz al uterului şobolanilor. Analele ştiinţifice ale USMF “Nicolae Testemiţanu”. 2006; I: 92-96.
  12. Polishchuk LZ, Grishchenko AF, Ganina KP. Quantitative changes in the karyotype during hyperplastic processes in cancer of the endometrium. Vopr Onkol. 1987; 33 (9): 47-54. [Russian].
  13. Schmidt G, Kannisto P, Owman C, Sjoberg NO. Is serotonin involved in the ovulatory process of the rat ovary perfused in vitro? Acta Physiol Scand. 1988 Feb; 132 (2): 251-6.
  14. Avtandilov GG. Meditsinskaya morfometriya. Moskva, 1990. 384 s.: il. [Russian].
  15. Baksheev NS, Milyanovskiy AI, Dudarenko VP, Frolova GD, Kolesnik LN. Serotonin v kompleksnom lechenii raka matki i yaichnikov. Akusherstvo i ginekologiya, 1975; 8: 47-51. [Russian].
  16. Bordunovskaya VP, Tsirkin VI, Filimonov VG. Vliyanie ryada sokrashchayushchikh matku sredstv na sokratitelnuyu aktivnost miometriya (v eksperimente). Akusherstvo i ginekologiya. 1979; 5: 55-7. [Russian].
  17. Kurskiy MD, Baksheev HC. Biokhimicheskie osnovy mekhanizma deystviya serotonina. Kiev, 1974. 294 s. [Russian].
  18. Lukin VA. Issledovanie katekholaminov i aktivnosti monoaminooksidazy v endometrii na protyazhenii normalnogo menstrualnogo tsikla. Akusherstvo i ginekologiya. 1975; 12: 22-4. [Russian].
  19. Avtorskoe svidetelstvo №1193497. G01N1/30, A61B10/00. Sposoby opredeleniya serotonina v kletkakh nervnoy tkani na gistologicheskom preparate / Lutan Vasiliy Stepanovich. 22 iyulya 1985. [Russian].
  20. Plekhova EI. Ob uchastii serotonina v protsessakh stanovleniya funktsiy zhenskoy polovoy sistemy. Okhrana zdorovya detey i podrostkov. 1973; 5: 93-7. [Russian].